Expertises

Translational research; cancer; anticancer drugs; cell culture; molecular biology

Main research areas

non-melanoma skin cancer; laser-assisted drug delivery; topical drug delivery; advanced imaging systems

Current research

 Currently, we are exploring the use of ablative fractional laser to facilitate localised, topical treatment with systemic anticancer drugs. This allows for more efficient treatment of skin cancer with reduced side-effects. Specifically, we aim to use the very promising systemically applied drugs, hedgehog inhibitors, for localised treatment of basal cell carcinomas, the most common cancer in humans. The project combines preclinical and clinical research, which is conducted in collaboration with the Technical University of Denmark, Harvard Medical School and University of Copenhagen. The research effort is supported by The Danish Council for Independent Research - Medical Sciences and The Research Foundation for Healthcare Research of the Capital Region of Denmark.

Potential conflicts of interest

No potential COI.